BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Retina
,
Avian flu virus
,
Doxorubicin
,
rs7903146
,
NEUROG3
,
Apoptosis
,
Ischemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NaC2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Cerebellum
Cerebellar vermis
Cerebellar hemisphere
Prefrontal cortex
Frontal lobe
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Epilepsy
Huntington's disease
Brain cancer
Lamellar ichthyosis
Neuroendocrine tumor
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Glial Cell Line-Derived Neurotrophic Factor
cidofovir
4'-deaza-1'-aza-2'-deoxy-1'-(9-methylene)-immucillin A
Laminin
n-hexanal
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
hsa-miR-375
MIR205
ZBTB7A
ASNA1
MIR141
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Epilepsy-associated SCN2A (NaV1.2) variants exhibit diverse and complex functional properties.
Inhibitory effect of atomoxetine on Nav1.2 voltage-gated sodium channel currents.
Pathogenic SCN2A variants cause early-stage dysfunction in patient-derived neurons.
A mutation in the neonatal isoform of SCN2A causes neonatal-onset epilepsy.
Functional correlates of clinical phenotype and severity in recurrent SCN2A variants.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ